10,205
Total Claims
$660K
Drug Cost
592
Beneficiaries
$1,116
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
+4%
Cost per patient vs peers
$1,116 vs $1,068 avg
+3%
Brand preference vs peers
9.2% vs 9.0% avg
Brand vs Generic
91% generic
Brand: 938 claims · $469K
Generic: 9,205 claims · $189K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 66 | $88K |
| Apixaban | 45 | $60K |
| Empagliflozin | 47 | $54K |
| Sitagliptin Phosphate | 18 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 35 | $23K |
| Dulaglutide | 11 | $21K |
| Fluticasone/Umeclidin/Vilanter | 11 | $14K |
| Fluticasone/Vilanterol | 16 | $11K |
| Rosuvastatin Calcium | 327 | $7,808 |
| Levothyroxine Sodium | 450 | $6,943 |
| Potassium Chloride | 239 | $6,528 |
| Bisoprolol/Hydrochlorothiazide | 144 | $6,240 |
| Omeprazole | 442 | $5,851 |
| Fluticasone Propion/Salmeterol | 13 | $5,704 |
| Atorvastatin Calcium | 414 | $5,566 |
Prescribing Profile
Patient Profile
73
Avg Age
49%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data